MB-CART2019.1 in Refractory Multiple Sclerosis
NCT07178431
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
CAR T Cell Therapy
Interventions
BIOLOGICAL:
MB-CART2019.1
Sponsor
Miltenyi Biomedicine GmbH